🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 641288105
- Market Cap
- Micro Cap · $39 Million
- IPO
- 4/22/2021 · $17:00/share
Business: Neuropace, Inc. is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures.
Company Contact
- CEO
- Michael Favet
- CFO
- Rebecca Kuhn
- Headquarters
- 455 N. Bernardo Avenue, Mountain View, CA 94043
- Phone
- 650-237-2700
- Investor Relations
- Matt Bacso, Gilmartin Group · investors@neuropace.com